Innospec | IOSP - Sales Revenues

Stock Price
86.08
Daily Change
-0.81 -0.93%
Monthly
9.50%
Yearly
-23.70%
Q1 Forecast
79.20

Innospec reported $441.9M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Akzo Nobel EUR 2.37B 180M Dec/2025
Arkema EUR 2.19B 210M Sep/2025
Ashland USD 386M 92M Dec/2025
Avient USD 807M 59.5M Sep/2025
Balchem USD 267.6M 12.1M Sep/2025
BASF EUR 14.33B 1.44B Sep/2025
Croda International GBP 413.5M 398.7M Jun/2025
Evogene USD 312K 572K Sep/2025
HB Fuller USD 894.79M 2.74M Sep/2025
Huntsman USD 1.46B 0 Sep/2025
Innospec USD 441.9M 2.2M Sep/2025
Minerals Technologies USD 520M 12.4M Dec/2025
NewMarket USD 690.31M 8.2M Sep/2025
Quaker Chemical USD 493.8M 10.4M Sep/2025
Rayonier Advanced Materials USD 352.84M 12.79M Sep/2025
Sensient Technologies USD 412.1M 2.1M Sep/2025
Solvay EUR 1.04B 60M Sep/2025
Stepan USD 590.28M 4.41M Sep/2025
Total Nigeria NGN 163.69B 38.58B Sep/2025
Valhi USD 503.5M 36.9M Sep/2025
Venator Materials USD 187.5K 9.9M Sep/2024